Understanding ADHD: Prevalence, Causes, Diagnosis, and Treatment in the UK Introducing GC Therapies – A New Telemedicine ADHD Service

Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental condition that affects both children and adults, impacting daily functioning, relationships, and overall quality of life.

As an ADHD specialist practitioner, I am often asked about the prevalence, causes, symptoms, and best approaches to diagnosis and treatment, particularly within the UK context.

ADHD Prevalence in the UK

ADHD is one of the most common neurodevelopmental disorders in childhood, affecting approximately 5% of school-aged children across the UK. Recent studies suggest that around 2.5% of adults in the UK live with ADHD, although many cases remain undiagnosed due to the misconception that ADHD is only a childhood condition. The growing awareness and improved diagnostic processes are helping more individuals receive appropriate support.

Causes of ADHD

The exact causes of ADHD are multifaceted, involving a combination of genetic and environmental factors. Research indicates that ADHD tends to run in families, highlighting a strong hereditary component. Environmental influences, such as premature birth, low birth weight, and exposure to toxins during pregnancy, may also play a role. However, it is important to note that no single cause has been identified, and ongoing studies continue to shed light on the complexity of ADHD.

Presentation: Symptoms Across Age Groups

ADHD presents differently depending on age and individual circumstances. In children, symptoms often include hyperactivity, impulsivity, and difficulty maintaining attention, which can affect academic performance and social interactions. Adults with ADHD may experience challenges with organisation, time management, and sustaining focus, sometimes accompanied by restlessness and impulsive decision-making. The impact of symptoms can vary widely from person to person.

Diagnostic Criteria and Assessment

Diagnosis of ADHD follows established criteria, typically outlined in the DSM-5 or ICD-11 guidelines. Assessment involves a thorough clinical interview, review of developmental history, and input from family or educators. Symptoms must be persistent, evident across multiple settings, and significantly impair daily functioning. Accurate diagnosis is crucial, as it guides appropriate treatment and support.

Treatment Options

Effective management of ADHD includes both pharmacological and non-pharmacological interventions. Medications such as methylphenidate and lisdexamfetamine are commonly prescribed to help regulate attention and impulsivity. Non-pharmacological approaches, including behavioural therapy, psychoeducation, and cognitive coaching, empower individuals and families to develop coping strategies and improve daily functioning. Tailoring treatment to each person’s needs is essential for best outcomes.

GC Therapies Launch: Accessible ADHD Support

GIVE Consulting is excited to announce the launch of GC Therapies, a new telemedicine ADHD assessment and treatment service designed for UK adults and families. Our specialist clinicians offer comprehensive assessments, personalised treatment plans, and ongoing support, all accessible from the comfort of your home.
To learn more about GC Therapies and check your eligibility, please visit www.gctherapies.co.uk.